FDAnews
www.fdanews.com/articles/160192-zs-pharma-reports-phase-iii-trial-results-of-hyperkalemia-drug

ZS Pharma Reports Phase III Trial Results of Hyperkalemia Drug

November 11, 2013
ZS Pharma has released the results of a Phase III trial of its ZS-003 hyperkalemia drug. The drug met its endpoint for reducing potassium.
Pharmaceutical Business Review